Pharma & Healthcare
Global Natural Killer Cells Therapeutics Market Research Report 2024
- Feb 19, 24
- ID: 54071
- Pages: 81
- Figures: 168
- Views: 17
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The global Natural Killer Cells Therapeutics market was valued at US$ 350 million in 2023 and is anticipated to reach US$ 1012.3 million by 2030, witnessing a CAGR of 16.4% during the forecast period 2024-2030.
A significant driver in the Natural Killer Cells Therapeutics market is the growing interest in immunotherapy approaches for cancer treatment. Natural killer (NK) cell-based therapeutics have emerged as a promising strategy to harness the body's immune system to combat cancer. However, a notable challenge in this market is the need for scalability and manufacturing standardization. Ensuring that NK cell therapies can be produced reliably at scale while addressing challenges related to cell expansion, quality control, and patient-specific manufacturing poses a significant challenge. Researchers and manufacturers must invest in technology advancements, quality assurance processes, and regulatory compliance to make NK cell-based therapeutics widely accessible and consistently effective in the fight against cancer.
This report aims to provide a comprehensive presentation of the global market for Natural Killer Cells Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cells Therapeutics.
Report Scope
The Natural Killer Cells Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Natural Killer Cells Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natural Killer Cells Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Affimed
Celgene
Fate Therapeutics
Fortress Biotech
Glycostem Therapeutics
Innate Pharma
Nantkwest
Nkarta Therapeutics
NKT Therapeutics
Ziopharm Oncology
Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Segment by Application
Cancer
Gastrointestinal Diseases
Immunoproliferative Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Natural Killer Cells Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Natural Killer Cells Therapeutics market was valued at US$ 350 million in 2023 and is anticipated to reach US$ 1012.3 million by 2030, witnessing a CAGR of 16.4% during the forecast period 2024-2030.
A significant driver in the Natural Killer Cells Therapeutics market is the growing interest in immunotherapy approaches for cancer treatment. Natural killer (NK) cell-based therapeutics have emerged as a promising strategy to harness the body's immune system to combat cancer. However, a notable challenge in this market is the need for scalability and manufacturing standardization. Ensuring that NK cell therapies can be produced reliably at scale while addressing challenges related to cell expansion, quality control, and patient-specific manufacturing poses a significant challenge. Researchers and manufacturers must invest in technology advancements, quality assurance processes, and regulatory compliance to make NK cell-based therapeutics widely accessible and consistently effective in the fight against cancer.
This report aims to provide a comprehensive presentation of the global market for Natural Killer Cells Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cells Therapeutics.
Report Scope
The Natural Killer Cells Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Natural Killer Cells Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natural Killer Cells Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Affimed
Celgene
Fate Therapeutics
Fortress Biotech
Glycostem Therapeutics
Innate Pharma
Nantkwest
Nkarta Therapeutics
NKT Therapeutics
Ziopharm Oncology
Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Segment by Application
Cancer
Gastrointestinal Diseases
Immunoproliferative Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Natural Killer Cells Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global Natural Killer Cells Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Immunoproliferative Disorders
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer Cells Therapeutics Market Perspective (2019-2030)
2.2 Natural Killer Cells Therapeutics Growth Trends by Region
2.2.1 Global Natural Killer Cells Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Natural Killer Cells Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Natural Killer Cells Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Natural Killer Cells Therapeutics Market Dynamics
2.3.1 Natural Killer Cells Therapeutics Industry Trends
2.3.2 Natural Killer Cells Therapeutics Market Drivers
2.3.3 Natural Killer Cells Therapeutics Market Challenges
2.3.4 Natural Killer Cells Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer Cells Therapeutics Players by Revenue
3.1.1 Global Top Natural Killer Cells Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Natural Killer Cells Therapeutics Revenue
3.4 Global Natural Killer Cells Therapeutics Market Concentration Ratio
3.4.1 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cells Therapeutics Revenue in 2023
3.5 Natural Killer Cells Therapeutics Key Players Head office and Area Served
3.6 Key Players Natural Killer Cells Therapeutics Product Solution and Service
3.7 Date of Enter into Natural Killer Cells Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer Cells Therapeutics Breakdown Data by Type
4.1 Global Natural Killer Cells Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2025-2030)
5 Natural Killer Cells Therapeutics Breakdown Data by Application
5.1 Global Natural Killer Cells Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Natural Killer Cells Therapeutics Market Size (2019-2030)
6.2 North America Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Natural Killer Cells Therapeutics Market Size by Country (2019-2024)
6.4 North America Natural Killer Cells Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Natural Killer Cells Therapeutics Market Size (2019-2030)
7.2 Europe Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Natural Killer Cells Therapeutics Market Size by Country (2019-2024)
7.4 Europe Natural Killer Cells Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Natural Killer Cells Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Natural Killer Cells Therapeutics Market Size (2019-2030)
9.2 Latin America Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Natural Killer Cells Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Natural Killer Cells Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Affimed
11.1.1 Affimed Company Detail
11.1.2 Affimed Business Overview
11.1.3 Affimed Natural Killer Cells Therapeutics Introduction
11.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.1.5 Affimed Recent Development
11.2 Celgene
11.2.1 Celgene Company Detail
11.2.2 Celgene Business Overview
11.2.3 Celgene Natural Killer Cells Therapeutics Introduction
11.2.4 Celgene Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.2.5 Celgene Recent Development
11.3 Fate Therapeutics
11.3.1 Fate Therapeutics Company Detail
11.3.2 Fate Therapeutics Business Overview
11.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Introduction
11.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.3.5 Fate Therapeutics Recent Development
11.4 Fortress Biotech
11.4.1 Fortress Biotech Company Detail
11.4.2 Fortress Biotech Business Overview
11.4.3 Fortress Biotech Natural Killer Cells Therapeutics Introduction
11.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.4.5 Fortress Biotech Recent Development
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Company Detail
11.5.2 Glycostem Therapeutics Business Overview
11.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Introduction
11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.5.5 Glycostem Therapeutics Recent Development
11.6 Innate Pharma
11.6.1 Innate Pharma Company Detail
11.6.2 Innate Pharma Business Overview
11.6.3 Innate Pharma Natural Killer Cells Therapeutics Introduction
11.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.6.5 Innate Pharma Recent Development
11.7 Nantkwest
11.7.1 Nantkwest Company Detail
11.7.2 Nantkwest Business Overview
11.7.3 Nantkwest Natural Killer Cells Therapeutics Introduction
11.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.7.5 Nantkwest Recent Development
11.8 Nkarta Therapeutics
11.8.1 Nkarta Therapeutics Company Detail
11.8.2 Nkarta Therapeutics Business Overview
11.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Introduction
11.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.8.5 Nkarta Therapeutics Recent Development
11.9 NKT Therapeutics
11.9.1 NKT Therapeutics Company Detail
11.9.2 NKT Therapeutics Business Overview
11.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Introduction
11.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.9.5 NKT Therapeutics Recent Development
11.10 Ziopharm Oncology
11.10.1 Ziopharm Oncology Company Detail
11.10.2 Ziopharm Oncology Business Overview
11.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Introduction
11.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.10.5 Ziopharm Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global Natural Killer Cells Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Immunoproliferative Disorders
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer Cells Therapeutics Market Perspective (2019-2030)
2.2 Natural Killer Cells Therapeutics Growth Trends by Region
2.2.1 Global Natural Killer Cells Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Natural Killer Cells Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Natural Killer Cells Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Natural Killer Cells Therapeutics Market Dynamics
2.3.1 Natural Killer Cells Therapeutics Industry Trends
2.3.2 Natural Killer Cells Therapeutics Market Drivers
2.3.3 Natural Killer Cells Therapeutics Market Challenges
2.3.4 Natural Killer Cells Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer Cells Therapeutics Players by Revenue
3.1.1 Global Top Natural Killer Cells Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Natural Killer Cells Therapeutics Revenue
3.4 Global Natural Killer Cells Therapeutics Market Concentration Ratio
3.4.1 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cells Therapeutics Revenue in 2023
3.5 Natural Killer Cells Therapeutics Key Players Head office and Area Served
3.6 Key Players Natural Killer Cells Therapeutics Product Solution and Service
3.7 Date of Enter into Natural Killer Cells Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer Cells Therapeutics Breakdown Data by Type
4.1 Global Natural Killer Cells Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2025-2030)
5 Natural Killer Cells Therapeutics Breakdown Data by Application
5.1 Global Natural Killer Cells Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Natural Killer Cells Therapeutics Market Size (2019-2030)
6.2 North America Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Natural Killer Cells Therapeutics Market Size by Country (2019-2024)
6.4 North America Natural Killer Cells Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Natural Killer Cells Therapeutics Market Size (2019-2030)
7.2 Europe Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Natural Killer Cells Therapeutics Market Size by Country (2019-2024)
7.4 Europe Natural Killer Cells Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Natural Killer Cells Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Natural Killer Cells Therapeutics Market Size (2019-2030)
9.2 Latin America Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Natural Killer Cells Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Natural Killer Cells Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Affimed
11.1.1 Affimed Company Detail
11.1.2 Affimed Business Overview
11.1.3 Affimed Natural Killer Cells Therapeutics Introduction
11.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.1.5 Affimed Recent Development
11.2 Celgene
11.2.1 Celgene Company Detail
11.2.2 Celgene Business Overview
11.2.3 Celgene Natural Killer Cells Therapeutics Introduction
11.2.4 Celgene Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.2.5 Celgene Recent Development
11.3 Fate Therapeutics
11.3.1 Fate Therapeutics Company Detail
11.3.2 Fate Therapeutics Business Overview
11.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Introduction
11.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.3.5 Fate Therapeutics Recent Development
11.4 Fortress Biotech
11.4.1 Fortress Biotech Company Detail
11.4.2 Fortress Biotech Business Overview
11.4.3 Fortress Biotech Natural Killer Cells Therapeutics Introduction
11.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.4.5 Fortress Biotech Recent Development
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Company Detail
11.5.2 Glycostem Therapeutics Business Overview
11.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Introduction
11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.5.5 Glycostem Therapeutics Recent Development
11.6 Innate Pharma
11.6.1 Innate Pharma Company Detail
11.6.2 Innate Pharma Business Overview
11.6.3 Innate Pharma Natural Killer Cells Therapeutics Introduction
11.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.6.5 Innate Pharma Recent Development
11.7 Nantkwest
11.7.1 Nantkwest Company Detail
11.7.2 Nantkwest Business Overview
11.7.3 Nantkwest Natural Killer Cells Therapeutics Introduction
11.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.7.5 Nantkwest Recent Development
11.8 Nkarta Therapeutics
11.8.1 Nkarta Therapeutics Company Detail
11.8.2 Nkarta Therapeutics Business Overview
11.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Introduction
11.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.8.5 Nkarta Therapeutics Recent Development
11.9 NKT Therapeutics
11.9.1 NKT Therapeutics Company Detail
11.9.2 NKT Therapeutics Business Overview
11.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Introduction
11.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.9.5 NKT Therapeutics Recent Development
11.10 Ziopharm Oncology
11.10.1 Ziopharm Oncology Company Detail
11.10.2 Ziopharm Oncology Business Overview
11.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Introduction
11.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.10.5 Ziopharm Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of NK Cell Therapies
Table 3. Key Players of NK Cell Directed Antibodies
Table 4. Global Natural Killer Cells Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Natural Killer Cells Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Natural Killer Cells Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Natural Killer Cells Therapeutics Market Share by Region (2019-2024)
Table 8. Global Natural Killer Cells Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Natural Killer Cells Therapeutics Market Share by Region (2025-2030)
Table 10. Natural Killer Cells Therapeutics Market Trends
Table 11. Natural Killer Cells Therapeutics Market Drivers
Table 12. Natural Killer Cells Therapeutics Market Challenges
Table 13. Natural Killer Cells Therapeutics Market Restraints
Table 14. Global Natural Killer Cells Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Natural Killer Cells Therapeutics Market Share by Players (2019-2024)
Table 16. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2023)
Table 17. Ranking of Global Top Natural Killer Cells Therapeutics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Natural Killer Cells Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Natural Killer Cells Therapeutics Product Solution and Service
Table 21. Date of Enter into Natural Killer Cells Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Natural Killer Cells Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2019-2024)
Table 25. Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2025-2030)
Table 27. Global Natural Killer Cells Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2019-2024)
Table 29. Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2025-2030)
Table 31. North America Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Natural Killer Cells Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Affimed Company Detail
Table 47. Affimed Business Overview
Table 48. Affimed Natural Killer Cells Therapeutics Product
Table 49. Affimed Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 50. Affimed Recent Development
Table 51. Celgene Company Detail
Table 52. Celgene Business Overview
Table 53. Celgene Natural Killer Cells Therapeutics Product
Table 54. Celgene Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Celgene Recent Development
Table 56. Fate Therapeutics Company Detail
Table 57. Fate Therapeutics Business Overview
Table 58. Fate Therapeutics Natural Killer Cells Therapeutics Product
Table 59. Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 60. Fate Therapeutics Recent Development
Table 61. Fortress Biotech Company Detail
Table 62. Fortress Biotech Business Overview
Table 63. Fortress Biotech Natural Killer Cells Therapeutics Product
Table 64. Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 65. Fortress Biotech Recent Development
Table 66. Glycostem Therapeutics Company Detail
Table 67. Glycostem Therapeutics Business Overview
Table 68. Glycostem Therapeutics Natural Killer Cells Therapeutics Product
Table 69. Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 70. Glycostem Therapeutics Recent Development
Table 71. Innate Pharma Company Detail
Table 72. Innate Pharma Business Overview
Table 73. Innate Pharma Natural Killer Cells Therapeutics Product
Table 74. Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 75. Innate Pharma Recent Development
Table 76. Nantkwest Company Detail
Table 77. Nantkwest Business Overview
Table 78. Nantkwest Natural Killer Cells Therapeutics Product
Table 79. Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 80. Nantkwest Recent Development
Table 81. Nkarta Therapeutics Company Detail
Table 82. Nkarta Therapeutics Business Overview
Table 83. Nkarta Therapeutics Natural Killer Cells Therapeutics Product
Table 84. Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 85. Nkarta Therapeutics Recent Development
Table 86. NKT Therapeutics Company Detail
Table 87. NKT Therapeutics Business Overview
Table 88. NKT Therapeutics Natural Killer Cells Therapeutics Product
Table 89. NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 90. NKT Therapeutics Recent Development
Table 91. Ziopharm Oncology Company Detail
Table 92. Ziopharm Oncology Business Overview
Table 93. Ziopharm Oncology Natural Killer Cells Therapeutics Product
Table 94. Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 95. Ziopharm Oncology Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Natural Killer Cells Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Natural Killer Cells Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. NK Cell Therapies Features
Figure 4. NK Cell Directed Antibodies Features
Figure 5. Global Natural Killer Cells Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Natural Killer Cells Therapeutics Market Share by Application: 2023 VS 2030
Figure 7. Cancer Case Studies
Figure 8. Gastrointestinal Diseases Case Studies
Figure 9. Immunoproliferative Disorders Case Studies
Figure 10. Others Case Studies
Figure 11. Natural Killer Cells Therapeutics Report Years Considered
Figure 12. Global Natural Killer Cells Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Natural Killer Cells Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Natural Killer Cells Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global Natural Killer Cells Therapeutics Market Share by Players in 2023
Figure 16. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Natural Killer Cells Therapeutics Revenue in 2023
Figure 18. North America Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Natural Killer Cells Therapeutics Market Share by Country (2019-2030)
Figure 20. United States Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Natural Killer Cells Therapeutics Market Share by Country (2019-2030)
Figure 24. Germany Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Natural Killer Cells Therapeutics Market Share by Region (2019-2030)
Figure 32. China Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Natural Killer Cells Therapeutics Market Share by Country (2019-2030)
Figure 40. Mexico Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Natural Killer Cells Therapeutics Market Share by Country (2019-2030)
Figure 44. Turkey Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Affimed Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 47. Celgene Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 48. Fate Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 49. Fortress Biotech Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 50. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 51. Innate Pharma Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 52. Nantkwest Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 53. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 54. NKT Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 55. Ziopharm Oncology Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of NK Cell Therapies
Table 3. Key Players of NK Cell Directed Antibodies
Table 4. Global Natural Killer Cells Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Natural Killer Cells Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Natural Killer Cells Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Natural Killer Cells Therapeutics Market Share by Region (2019-2024)
Table 8. Global Natural Killer Cells Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Natural Killer Cells Therapeutics Market Share by Region (2025-2030)
Table 10. Natural Killer Cells Therapeutics Market Trends
Table 11. Natural Killer Cells Therapeutics Market Drivers
Table 12. Natural Killer Cells Therapeutics Market Challenges
Table 13. Natural Killer Cells Therapeutics Market Restraints
Table 14. Global Natural Killer Cells Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Natural Killer Cells Therapeutics Market Share by Players (2019-2024)
Table 16. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2023)
Table 17. Ranking of Global Top Natural Killer Cells Therapeutics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Natural Killer Cells Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Natural Killer Cells Therapeutics Product Solution and Service
Table 21. Date of Enter into Natural Killer Cells Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Natural Killer Cells Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2019-2024)
Table 25. Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2025-2030)
Table 27. Global Natural Killer Cells Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2019-2024)
Table 29. Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2025-2030)
Table 31. North America Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Natural Killer Cells Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Natural Killer Cells Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Affimed Company Detail
Table 47. Affimed Business Overview
Table 48. Affimed Natural Killer Cells Therapeutics Product
Table 49. Affimed Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 50. Affimed Recent Development
Table 51. Celgene Company Detail
Table 52. Celgene Business Overview
Table 53. Celgene Natural Killer Cells Therapeutics Product
Table 54. Celgene Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Celgene Recent Development
Table 56. Fate Therapeutics Company Detail
Table 57. Fate Therapeutics Business Overview
Table 58. Fate Therapeutics Natural Killer Cells Therapeutics Product
Table 59. Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 60. Fate Therapeutics Recent Development
Table 61. Fortress Biotech Company Detail
Table 62. Fortress Biotech Business Overview
Table 63. Fortress Biotech Natural Killer Cells Therapeutics Product
Table 64. Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 65. Fortress Biotech Recent Development
Table 66. Glycostem Therapeutics Company Detail
Table 67. Glycostem Therapeutics Business Overview
Table 68. Glycostem Therapeutics Natural Killer Cells Therapeutics Product
Table 69. Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 70. Glycostem Therapeutics Recent Development
Table 71. Innate Pharma Company Detail
Table 72. Innate Pharma Business Overview
Table 73. Innate Pharma Natural Killer Cells Therapeutics Product
Table 74. Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 75. Innate Pharma Recent Development
Table 76. Nantkwest Company Detail
Table 77. Nantkwest Business Overview
Table 78. Nantkwest Natural Killer Cells Therapeutics Product
Table 79. Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 80. Nantkwest Recent Development
Table 81. Nkarta Therapeutics Company Detail
Table 82. Nkarta Therapeutics Business Overview
Table 83. Nkarta Therapeutics Natural Killer Cells Therapeutics Product
Table 84. Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 85. Nkarta Therapeutics Recent Development
Table 86. NKT Therapeutics Company Detail
Table 87. NKT Therapeutics Business Overview
Table 88. NKT Therapeutics Natural Killer Cells Therapeutics Product
Table 89. NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 90. NKT Therapeutics Recent Development
Table 91. Ziopharm Oncology Company Detail
Table 92. Ziopharm Oncology Business Overview
Table 93. Ziopharm Oncology Natural Killer Cells Therapeutics Product
Table 94. Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)
Table 95. Ziopharm Oncology Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Natural Killer Cells Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Natural Killer Cells Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. NK Cell Therapies Features
Figure 4. NK Cell Directed Antibodies Features
Figure 5. Global Natural Killer Cells Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Natural Killer Cells Therapeutics Market Share by Application: 2023 VS 2030
Figure 7. Cancer Case Studies
Figure 8. Gastrointestinal Diseases Case Studies
Figure 9. Immunoproliferative Disorders Case Studies
Figure 10. Others Case Studies
Figure 11. Natural Killer Cells Therapeutics Report Years Considered
Figure 12. Global Natural Killer Cells Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Natural Killer Cells Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Natural Killer Cells Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global Natural Killer Cells Therapeutics Market Share by Players in 2023
Figure 16. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Natural Killer Cells Therapeutics Revenue in 2023
Figure 18. North America Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Natural Killer Cells Therapeutics Market Share by Country (2019-2030)
Figure 20. United States Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Natural Killer Cells Therapeutics Market Share by Country (2019-2030)
Figure 24. Germany Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Natural Killer Cells Therapeutics Market Share by Region (2019-2030)
Figure 32. China Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Natural Killer Cells Therapeutics Market Share by Country (2019-2030)
Figure 40. Mexico Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Natural Killer Cells Therapeutics Market Share by Country (2019-2030)
Figure 44. Turkey Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Affimed Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 47. Celgene Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 48. Fate Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 49. Fortress Biotech Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 50. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 51. Innate Pharma Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 52. Nantkwest Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 53. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 54. NKT Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 55. Ziopharm Oncology Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Food Grade FIBC Bulk Bags Market Research Report 2025
Jan 09, 25
Global Standard FIBC Market Research Report 2025
Jan 09, 25
Global Mammoplasty Retractors Market Research Report 2025
Jan 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232